Search Tag: COVID-19 vaccine trial

Executive Health Management

Fda-approves-pfizer-covid-19-boosters-for-older-and-at-risk-people

2021 23 Sep

Today, 23 September, the US FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to permit a booster dose for those who are 65 years and older, who are at risk for severe disease, and whose professions bring them occupational exposure. This booster dose can be administered at least six months after completion of the primary two-dose regimen....Read more

Executive Health Management

Pfizer-says-covid-19-vaccine-safe-for-children-ages-5-and-up

2021 21 Sep

Given that children and adolescents can get sick with COVID-19, attending K-12 schools in-person remains a risk. According to the American Academy of Pediatrics, children accounted for 25.7% of US cases for the week of 16 September (American Academy of Pediatrics, 2021), while hospitalisations averaged 311 children/day (Centers for Disease Control...Read more

Executive Health Management

First-covid-19-vaccine-trial-in-children

2021 17 Mar

Moderna has begun testing its COVID-19 vaccine in children ages 6 months to less than 12 years. This is the first such study with paediatric participants.   You might also like: Moderna and IBM will work together on implementation of technologies such as artificial intelligence, blockchain and hybrid cloud, to improve COVID-19 vaccine management...Read more

Executive Health Management

Eu-plan-to-manage-coronavirus-mutations

2021 18 Feb

HERA Incubator, a new bio-defence preparedness programme in the EU, will receive €150 million to manage novel coronavirus mutations and ensure access to effective vaccines against them.   You might also like: The European Commission has called member states to accelerate the roll-out of their vaccination programmes. The aim is...Read more

Executive Health Management

Major-moves-with-covid-19-vaccines

2020 02 Dec

The UK, first in the world, authorises Pfizer COVID-19 vaccine and is looking into fast-tracking AstraZeneca’s. In the meantime, Pfizer and Moderna both file applications for their vaccines’ emergency use in the U.S. and Europe.   You might also like: Coronavirus, Tensegrity and CSR: Year of Living Dangerously   The...Read more

Executive Health Management

Covid-19-vaccines-tracking-and-future-distribution

2020 30 Oct

Availability of an effective vaccine is viewed as crucial in the fight against COVID-19, but researchers warn against ‘vaccine nationalism’. The latest vaccine development updates are aggregated in a new online tracker.   You might also like: Grand Plans for Potential COVID-19 Vaccine Production   Cost of ‘Vaccine Nationalism’...Read more

Executive Health Management

Az-covid-19-trial-continues-despite-participants-death

2020 23 Oct

This week has seen another COVID-19 vaccine-related incident: a volunteer in the AstraZeneca (AZ) vaccine trial in Brazil has died. Nevertheless, the trial continues as might the previously halted Johnson & Johnson’s (J&J) and the U.S. arm of AZ’s trial.   You might also like: Rushing COVID-19 Vaccine Development: Is It Justified?...Read more